Form Heading

Tag: finance

Page 1 of 3 1 2 3

FEATURED NEWS

  • fish covered with necklace and stylish jacketHepion Pharmaceuticals Inc $HEPA: Crazy Amount Of Cash In Hand

    Balance Sheet As Of 2020-12-31

    HEPA shows $40 million in cash and cash equivalents. In my experience, the company has a good amount of cash to conduct additional R&D and increase its marketing efforts. Moreover, Hepion Pharmaceuticals Inc has positive working capital, which market participants will like. It means that HEPA can cover its short-term liabilities when they come due. HEPA's short term debt is less significant than the company's cash and cash equivalents. In my experience, Hepion Pharmaceuticals Inc may not have to worry about any liquidity risk. Moreover, the price to book value is below 1. 5x, which means that HEPA is undervalued. Hepion Pharmaceuticals Inc has $48 million in total assets, and $8 million in total liabilities. In my experience, HEPA is cheap. Additionally, notice that the cash per share is equal to $4, and the stock price is $1. 91. HEPA's debt to equity ratio is below 2x. In short, the debt level appears to be under control. Note that Hepion Pharmaceuticals Inc reports cash and cash equivalents of $40 million, and net debt of $-40 million. With regards to the EV/EBITDA, Hepion Pharmaceuticals Inc trades at 1. I feel that market participants will most likely appreciate this low figure. …
  • Verastem (NASDAQ:VSTM) Delivered Double Digit Returns
    Verastem (NASDAQ:VSTM) reported a global licensing agreement with Chugai Pharmaceutical (OTCPK:CHGCF) to develop rights to RAF/MEK inhibitor CH5126766 for KRAS-mutant solid tumors. Yesterday, …
  • 5 Reasons To Short NIO
    The increase in short positions in NIO (NIO), the manufacturer of electric vehicles, is impressive. Many short sellers believe that they will be making tons of dollars when the share price collapses …
  • IOUPAY LIMITED, AUSTRALIAN: PROSPECT BEYOND PANDEMIC
    The stock market always has a few surprises in store, as any investor would attest. However, the biggest factor experts are considering as they identify the best stocks to buy for 2021 is the same factor that dominated 2020: A few of these stocks have been overbearing for a long time and simply look primed to continue their success for yet another year. …

Login to your account below

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.